Q4 2021 Holdings
Filed 2022-02-14 | 97 holdings | $990.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Abbvie Inc(ABBV) | COM | 00287Y109 | $268.8M | 1,985,000 | 27.1% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $207.6M | 2,527,973 | 21.0% |
| Avantor Inc(AVTR) | COM | 05352A100 | $201.9M | 4,792,000 | 20.4% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $62.7M | 370,000 | 6.3% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $58.0M | 875,000 | 5.9% |
| Caribou Biosciences Inc(CRBU) | COM | 142038108 | $40.4M | 2,674,067 | 4.1% |
| AMN Healthcare Svcs Inc(AMN) | COM | 001744101 | $34.3M | 280,100 | 3.5% |
| Alphatec Hldgs Inc(ATEC) | COM NEW | 02081G201 | $31.7M | 2,773,000 | 3.2% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $29.3M | 775,000 | 3.0% |
| Altimmune Inc(ALT) | COM NEW | 02155H200 | $25.3M | 2,765,000 | 2.6% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $13.5M | 851,522 | 1.4% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $7.0M | 300,000 | 0.7% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $6.3M | 2,000,000 | 0.6% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $228.2K | 2,715,000 | 0.0% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $167.0K | 2,867,200 | 0.0% |
| Biohaven Pharmactl Hldg Co L(BHVN) | COM | G11196105 | $157.1K | 1,140,000 | 0.0% |
| Baxter Intl Inc(BAX) | COM | 071813109 | $151.5K | 1,765,000 | 0.0% |
| Anthem Inc(ELV) | COM | 036752103 | $148.8K | 321,000 | 0.0% |
| Pfizer Inc(PFE) | COM | 717081103 | $123.4K | 2,090,000 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $118.3K | 806,400 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $116.3K | 6,955,000 | 0.0% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $115.6K | 535,000 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COM NEW | 040047607 | $113.0K | 1,215,500 | 0.0% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $109.1K | 1,012,000 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $107.3K | 1,260,000 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $106.6K | 995,000 | 0.0% |
| Seagen Inc(SGENUSD) | COM | 81181C104 | $105.9K | 685,000 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $105.6K | 4,823,400 | 0.0% |
| Lilly ELI & Co(LLY) | COM | 532457108 | $95.2K | 344,800 | 0.0% |
| Catalent Inc(CTLTEUR) | COM | 148806102 | $89.0K | 695,000 | 0.0% |
| Natera Inc(NTRA) | COM | 632307104 | $87.8K | 940,000 | 0.0% |
| Hologic Inc(HOLX) | COM | 436440101 | $81.5K | 1,064,000 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $72.2K | 3,780,000 | 0.0% |
| Sotera Health Co(SHC) | COM | 83601L102 | $69.7K | 2,960,000 | 0.0% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $62.8K | 7,382,488 | 0.0% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $61.8K | 123,100 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $61.5K | 280,000 | 0.0% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $60.4K | 2,553,000 | 0.0% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $58.9K | 700,000 | 0.0% |
| Stevanato Group S P A(STVN) | ORD SHS | T9224W109 | $57.1K | 2,541,893 | 0.0% |
| Gritstone BIO Inc(2JQ) | COM | 39868T105 | $56.2K | 4,370,000 | 0.0% |
| Kezar Life Sciences Inc | COM | 49372L100 | $54.0K | 3,228,200 | 0.0% |
| Adicet BIO Inc(TORCEUR) | COM | 007002108 | $53.1K | 3,034,004 | 0.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $43.1K | 1,815,000 | 0.0% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $42.5K | 670,000 | 0.0% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $42.1K | 1,230,000 | 0.0% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $39.5K | 1,450,000 | 0.0% |
| Ortho Clinical Diagnostics H | ORD SHS | G6829J107 | $38.3K | 1,790,000 | 0.0% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $37.3K | 1,896,000 | 0.0% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $34.9K | 2,460,000 | 0.0% |